Tentando aprender a traduzir a partir dos exemplos de tradução humana.
A partir de tradutores profissionais, empresas, páginas da web e repositórios de traduções disponíveis gratuitamente
Δκπεηξία κεηά ηελ θπθινθνξία
post-marketing experience
Última atualização: 2017-04-26
Frequência de uso: 1
Qualidade:
Κάηνρνο αδείαο θπθινθνξία θαη παξαγσγόο
marketing authorisation holder and manufacturer
Última atualização: 2012-04-11
Frequência de uso: 2
Qualidade:
Δκπεηξία κεηά ηελ θπθινθνξία ηνπ θαξκάθνπ:
post-marketing experience:
Última atualização: 2017-04-26
Frequência de uso: 1
Qualidade:
Καλέλαο κεηαβνιίηεο δελ αλεπξίζθεηαη ζηε ζπζηεκαηηθή θπθινθνξία.
no metabolites are seen in the systemic circulation.
Última atualização: 2012-04-11
Frequência de uso: 2
Qualidade:
ε δεδνκέλα κεηά ηελ θπθινθνξία, αλαθέξζεθαλ 305 πεξηπηψζεηο δάιεο.
in post-marketing data, 305 cases of dizziness were reported.
Última atualização: 2017-04-26
Frequência de uso: 1
Qualidade:
Σν mirabegron είλαη ην θχξην ζπζηαηηθφ ζηελ θπθινθνξία κεηά απφ άπαμ δφζε 14c-mirabegron.
mirabegron is the major circulating component following a single dose of 14c-mirabegron.
Última atualização: 2017-04-26
Frequência de uso: 1
Qualidade:
Πίλαθαο 2: πλνπηηθή πεξίιεςε ησλ αλεπηζύκεησλ ελεξγεηώλ πνπ ζρεηίδνληαη κε ην emtricitabine βάζεη ησλ θιηληθώλ κειεηώλ θαη ηεο εκπεηξίαο κεηά ηελ θπθινθνξία
table 2: tabulated summary of adverse reactions associated with emtricitabine based on clinical study and post-marketing experience
Última atualização: 2017-04-26
Frequência de uso: 1
Qualidade:
3 Απηή ε αλεπηζχκεηε ελέξγεηα, ε νπνία αλαγλσξίζηεθε κέζσ ηεο παξαθνινχζεζεο κεηά ηελ θπθινθνξία, δελ παξαηεξήζεθε ζε ηπραηνπνηεκέλεο ειεγρφκελεο θιηληθέο κειέηεο ζε ελήιηθεο ή ζε θιηληθέο κειέηεο ηεο emtricitabine ζε παηδηαηξηθνχο αζζελείο κε hiv.
3 this adverse reaction, which was identified through post-marketing surveillance, was not observed in randomised controlled clinical trials in adults or paediatric hiv clinical trials of emtricitabine.
Última atualização: 2017-04-26
Frequência de uso: 1
Qualidade:
Καηά ηελ εκπεηξία κεηά ηελ θπθινθνξία ηνπ θαξκάθνπ, έρνπλ αλαθεξζεί ζε αζζελείο ζηελ νκάδα θηλδχλνπ λεθξηθή δπζιεηηνπξγία θαη πεξηπηψζεηο νμείαο λεθξηθήο αλεπάξθεηαο (βι. παξάγξαθν 4.4).
in post-marketing experience, renal dysfunction and cases of acute renal failure have been reported in patients at risk (see section 4.4).
Última atualização: 2017-04-26
Frequência de uso: 1
Qualidade:
Αληίζηξνθα, θαηά ηελ εκπεηξία κεηά ηελ θπθινθνξία ηνπ θαξκάθνπ έρνπλ παξαηεξεζεί απμήζεηο ηνπ θαιίνπ νξνχ κε ηελ αιηζθηξέλε θαη απηέο κπνξεί λα επηδεηλσζνχλ κε ηελ ηαπηφρξνλε ρξήζε άιισλ παξαγφλησλ πνπ δξνπλ ζην ΡΑΑ ή κε κε ζηεξνεηδή αληηθιεγκνλψδε θάξκαθα (ΜΑΦ).
conversely, increases in serum potassium have been observed with aliskiren in post-marketing experience and these may be exacerbated by concomitant use of other agents acting on the raas or by non-steroidal anti-inflammatory drugs (nsaids).
Última atualização: 2017-04-26
Frequência de uso: 1
Qualidade: